News
Ray of hope for HIV patients, as Hyderabad-based pharma giants secure nod for game-changing HIV drug
Indian firms have secured rights to produce Lenacapavir, a twice-yearly HIV injection, making treatment easier and affordable ...
HIV targets the white blood cells and weakens the immune system. This would make the person prone to diseases like ...
WASHINGTON — The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global ...
Like other PrEP drugs, if enough of the medication is present when a person is exposed to HIV, it can prevent the virus from ...
The National Institutes of Health office responsible for issuing federal guidelines related to treatment of HIV and AIDS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results